NanoDocNanoDoc

About Us

A cross-border partnership in science and enterprise

NanoDoc International Pte Ltd is the South East Asia representative of LG Bionano Co., Ltd (Xiamen) and LG Bionano, LLC (Delaware, USA) — specialists in nanobiotechnology delivery systems for a full range of nutraceutical and cosmeceutical products. Our leadership team brings together institutional finance discipline, operational execution, regional enterprise experience, and the pharmaceutical science that underpins every formulation we bring to market.

Leadership

Dr. Timothy Wu (Chien-Chin Wu)

Dr. Timothy Wu (Chien-Chin Wu)

Founder & Chairman, LG Bionano, LLC

Dr. Timothy Wu is the Founder and Chairman of LG Bionano, LLC, the Delaware, USA innovator behind the proprietary bionano platform technology that underpins every NanoDoc formulation. NanoDoc International Pte Ltd is proud to represent LG Bionano's science across South East Asia.

Dr. Wu holds a B.S. in Pharmacy from Taipei Medical College, an M.S. in Molecular Biology from National Hsin Hua University, and a Ph.D. in Pharmaceutics and Pharmaceutical Chemistry from the College of Pharmacy, The Ohio State University, USA.

His career spans more than three decades of pharmaceutical R&D leadership in the United States, including roles as Group Leader at Ayerst Laboratory, R&D Manager at DuPont Pharmaceutical Company, R&D Associate Director at DuPont Merck Pharmaceutical Company, and R&D Director and later Vice President of Scientific Affairs at Luitpold Pharmaceutical Company — where he led teams spanning R&D, Regulatory Affairs, Quality Control and Quality Assurance to secure FDA approvals for human drugs, animal drugs and dental care products.

He went on to serve as General Manager of UBI Asia, establishing a biotech company for specialty generic and proprietary peptide drugs, and as Chief Scientific Officer of Advanced Pharmaceutical Nanotech Company, where he executed the development of bionano products and established a manufacturing base in Asia.

Since 2009, as Founder, Chairman and CEO of LG Bionano, LLC, Dr. Wu has directed the development and execution of proprietary bionano platform technologies for novel pharmaceutical, nano-dermatology and nano-healthcare products, established the company's global patent strategy, and built its development and manufacturing base in China's Hi-Tech Park — the same science and manufacturing foundation that powers the NanoDoc product range today.

Dr. Paul Sene

Dr. Paul Sene

Executive Chairman, NanoDoc International Pte Ltd

Dr. Paul Sene is Executive Chairman of NanoDoc International Pte Ltd, and a seasoned entrepreneur and corporate leader who has shown strong leadership and sharp business acumen since establishing his own business in 1991.

Dr. Sene's key strength lies in his extensive regional knowledge of social, political and economic conditions, which he has used to strategically position businesses and capitalize on opportunities — an ability reflected in his track record across multiple successful ventures and a talent for identifying good business and capable people.

He is also Director and founder of SIF Technologies Pte Ltd, a Singapore-based ecological and environmental engineering company operating across the Asia-Pacific region. In 2002, Dr. Sene developed a patented, chemical-free proprietary technology recognized by Singapore's Economic Development Board (EDB), and in October 2004 the company became one of the SEEDS enterprises to receive EDB funding, serving clients across agriculture, aquaculture, manufacturing and hospitality. Building on his patented water technology, he went on to establish a bottling plant and water purification plant in Asia.

Dr. Sene is also a shareholder and part-owner of a manufacturing and distribution business for heat pads, operational in Michigan, USA since 2004. In his latest venture, he joined with his partners to found NanoDoc International Pte Ltd in Singapore, bringing nanotechnology-based health and beauty supplements to the region.

Bryan Chew

Bryan Chew

Chief Executive Officer, NanoDoc International Pte Ltd

Bryan Chew is the Chief Executive Officer of NanoDoc International Pte Ltd. He holds a degree in Finance as well as Nutrition — a combination that uniquely equips him to lead a nutraceutical and cosmeceutical enterprise with both institutional financial discipline and a genuine, science-grounded understanding of nutrition and wellness.

He brings over four decades of senior leadership experience across finance, investment, commodities, infrastructure and cross-border enterprises. His career spans executive and advisory roles in investment banking, mergers and acquisitions, trust and fund structures, commodities, construction, marine, oil and gas, and healthcare, with leadership positions held across public-listed companies, multinational corporations and privately held enterprises.

As CEO of NanoDoc, Bryan provides strategic direction, governance oversight and mandate stewardship, ensuring the company operates with institutional discipline, integrity and a long-term value orientation — while his grounding in nutrition science informs how NanoDoc evaluates, positions and stands behind every product it brings to market.

Steven Chong

Steven Chong

Chief Operating Officer, NanoDoc International Pte Ltd

Steven Chong serves as Chief Operating Officer of NanoDoc International Pte Ltd, overseeing operational execution, mandate coordination and platform development.

With more than three decades of experience across technology, operations, commodities, energy and healthcare sectors, Steven brings a structured, systems-driven approach to managing complex projects, combining operational leadership with a strong foundation in technology and digital infrastructure.

At NanoDoc, Steven focuses on execution discipline, cross-functional coordination and risk management, ensuring that mandates are delivered efficiently and in alignment with regulatory, commercial and governance standards.

Steven is also a hands-on practitioner of modern AI tooling, applying large language model platforms including Claude, ChatGPT and OpenClaw to accelerate operational and digital work. This website itself was designed and built using Claude Code — a direct reflection of his belief in putting practical AI capability to work in the business.